NYSE: ABBV
Abbvie Inc Earnings Dates, Reports, Calls

Abbvie earnings were $5.1B for the trailing 12 months ending Sep 30, 2024, with -21.3% growth year over year. The latest ABBV earnings report on Sep 30, 2024 announced Q3 2024 earnings of $1.6B, up 13.9% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ABBV reported annual earnings of $4.9B, with -58.9% growth.

ABBV past earnings growth

How has ABBV's earnings growth performed historically?

Company
-21.31%
Industry
7.64%
Market
48.53%
ABBV's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ABBV's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ABBV's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ABBV earnings history

Current Revenue
$55.5B
Current Earnings
$5.1B
Current Profit Margin
9.2%
ABBV's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ABBV Return on Equity

Current Company
65.7%
Current Industry
40.9%
Current Market
35%
ABBV's Return on Equity (65.7%)... subscribe to Premium to read more.
High Return on Equity Performance

ABBV Return on Assets

Current Company
3.6%
Current Industry
8.2%
ABBV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ABBV announces earnings.

ABBV Return on Capital Employed

Current Company
9.08%
Current Industry
13.9%
ABBV has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ABBV vs General Drug Manufacturer Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ABBV$17.47B$5.12B+4.88%$2.88
JNJ$24.65B$14.68B+2.54%$6.03
MRK$19.22B$12.15B+5.82%$4.79
AZN$15.35B$6.50B+21.02%$2.09
NVS$24.88B$11.94B+2.95%$5.92

Abbvie Earnings Reports & History FAQ

What were Abbvie's earnings last quarter?

On ABBV's earnings call on Invalid Date, Abbvie (NYSE: ABBV) reported Q3 2024 earnings per share (EPS) of $0.88, up 12% year over year. Total ABBV earnings for the quarter were $1.56 billion. In the same quarter last year, Abbvie's earnings per share (EPS) was $1.00.

If you're new to stock investing, here's how to buy Abbvie stock.

Is Abbvie profitable or losing money?

As of the last Abbvie earnings report, Abbvie is currently profitable. Abbvie's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $5.12 billion, a 21.37% decrease year over year.

What was ABBV's earnings growth in the past year?

As of Abbvie's earnings date in Invalid Date, Abbvie's earnings has grown -21.31% year over year. This is 28.95 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 7.64%. ABBV earnings in the past year totalled $5.12 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.